The first regulatory submission for a CRISPR-based therapy has been validated by the European Medicines Agency, to treat sickle cell disease and transfusion-dependent beta thalassemia.

Peer Review Toolkit
Scientists receive too little peer-review training. Here’s one method from Nature for effectively peer-reviewing papers.